RxDoctor Payments Data

eyeMAX Digital Controller: payments to doctors

Payments that named eyeMAX Digital Controller as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Was your doctor paid by Micro-tech Endoscopy USA, Inc.?

Micro-tech Endoscopy USA, Inc. reported the most payments naming eyeMAX Digital Controller. Search your clinician to see whether they are among them — and what else they were paid for.

Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.

Total reported
$47K
Providers
0
Transactions
11
Average per transaction
$4,230

The per-transaction average — $4,230 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. No payment naming this product was reported to an individual clinician. The Sunshine Act also covers payments to teaching hospitals as institutions — research funding, grants and device loans — and for this product that is all of it.

Companies reporting these payments

CompanyTotal reportedShare
Micro-tech Endoscopy USA, Inc.$46,534100.0%

Other products from Micro-tech Endoscopy USA, Inc.

The company that reported the most payments naming eyeMAX Digital Controller also reports against these.

← All drugs & devices